相似文献
1
Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.
Anal Chim Acta. 2006 Mar 30;564(1):74-81. doi: 10.1016/j.aca.2005.11.083. Epub 2006 Jan 23.
2
Decentralized data sharing of tissue microarrays for investigative research in oncology.
Cancer Inform. 2007 Jun 6;2:373-88.
3
TmaDB: a repository for tissue microarray data.
BMC Bioinformatics. 2005 Sep 1;6:218. doi: 10.1186/1471-2105-6-218.
4
Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).
Microarrays (Basel). 2014 Apr 15;3(2):91-102. doi: 10.3390/microarrays3020091.
5
Tissue microarray (TMA) applications: implications for molecular medicine.
Expert Rev Mol Med. 2003 Oct 21;5(26):1-12. doi: 10.1017/S1462399403006781.
6
High-throughput microarray technologies: from genomics to clinics.
Eur Urol. 2001 Aug;40(2):231-8. doi: 10.1159/000049777.
7
ATMAD: robust image analysis for Automatic Tissue MicroArray De-arraying.
BMC Bioinformatics. 2018 Apr 19;19(1):148. doi: 10.1186/s12859-018-2111-8.
8
The tissue microarray object model: a data model for storage, analysis, and exchange of tissue microarray experimental data.
Arch Pathol Lab Med. 2006 Jul;130(7):1004-13. doi: 10.5858/2006-130-1004-TTMOMA.
9
The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data.
BMC Med Inform Decis Mak. 2003 May 23;3:5. doi: 10.1186/1472-6947-3-5.
10
Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms.
Histochem Cell Biol. 2017 Jan;147(1):75-82. doi: 10.1007/s00418-016-1476-x. Epub 2016 Aug 20.
引用本文的文献
1
DJ-1 Oncogene as a Potential Diagnostic and Prognostic Biomarker for Head and Neck Cancer.
Cureus. 2023 Mar 16;15(3):e36229. doi: 10.7759/cureus.36229. eCollection 2023 Mar.
2
Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.
J Gastrointest Cancer. 2019 Sep;50(3):478-484. doi: 10.1007/s12029-018-0103-6.
3
A benchmark for comparing precision medicine methods in thyroid cancer diagnosis using tissue microarrays.
Bioinformatics. 2018 May 15;34(10):1767-1773. doi: 10.1093/bioinformatics/btx838.
4
Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).
Microarrays (Basel). 2014 Apr 15;3(2):91-102. doi: 10.3390/microarrays3020091.
5
Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It.
Microarrays (Basel). 2015 May 11;4(2):245-54. doi: 10.3390/microarrays4020245.
6
Recent developments in multiplexing techniques for immunohistochemistry.
Expert Rev Mol Diagn. 2015;15(9):1171-86. doi: 10.1586/14737159.2015.1069182. Epub 2015 Aug 6.
7
Mechanical phenotyping of breast cancer using MEMS: a method to demarcate benign and cancerous breast tissues.
Lab Chip. 2014 Dec 7;14(23):4523-32. doi: 10.1039/c4lc00594e. Epub 2014 Sep 30.
8
Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.
Int J Med Sci. 2013 Jul 31;10(9):1217-23. doi: 10.7150/ijms.6054. Print 2013.
9
Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study.
Arch Gynecol Obstet. 2013 Oct;288(4):889-99. doi: 10.1007/s00404-013-2840-x. Epub 2013 Apr 13.
10
ImageMiner: a software system for comparative analysis of tissue microarrays using content-based image retrieval, high-performance computing, and grid technology.
J Am Med Inform Assoc. 2011 Jul-Aug;18(4):403-15. doi: 10.1136/amiajnl-2011-000170. Epub 2011 May 23.
本文引用的文献
1
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.
Genomics. 2005 Aug;86(2):127-41. doi: 10.1016/j.ygeno.2005.04.008.
2
Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.
Blood. 2005 Sep 1;106(5):1831-8. doi: 10.1182/blood-2004-10-3898. Epub 2005 May 24.
3
E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Histopathology. 2005 Jun;46(6):685-93. doi: 10.1111/j.1365-2559.2005.02156.x.
4
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
Int J Cancer. 2005 Sep 1;116(3):340-50. doi: 10.1002/ijc.21004.
5
Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Pathol Res Pract. 2005;200(11-12):783-90. doi: 10.1016/j.prp.2004.10.004.
6
A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: examples with prostate cancer.
Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):96-103. doi: 10.1097/00129039-200503000-00016.
7
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):638-45.
8
Overexpression of clusterin in human hepatocellular carcinoma.
Hum Pathol. 2004 Nov;35(11):1340-6. doi: 10.1016/j.humpath.2004.07.021.
9
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
Cancer Res. 2004 Dec 1;64(23):8767-72. doi: 10.1158/0008-5472.CAN-04-1384.
10
Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma.
Mod Pathol. 2005 Apr;18(4):547-57. doi: 10.1038/modpathol.3800322.
Zotero 插件